Skip to content

â??Beneficial non-specific effects of BCG-Green signal and zero dose polio on neonatal survival in babies less than 2000 gram.

Beneficial Non-specific Effects of BCG-Green signal and Zero dose Polio on Neonatal survival in babies less than 2000 gram - A Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015424
Enrollment
1998
Registered
2018-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P071- Other low birth weight newborn

Interventions

Intervention1: BCG Green Signal (originally derived from BCG Denmark) : Low-birth-weight babies will receive BCG-Green Signal plus OPV as soon as possible after admission to NICU (BCG group) Control

Sponsors

Chinnathambi Kamalarathnam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all babies weighing less than 2000 grams at the time of admission to NICU

Exclusion criteria

Exclusion criteria: 1) Babies less than 60 minutes of age (2) Babies not likely to survive more than 24 hours (3) Babies older than 21 days of age (4) Babies with a major life-threatening malformation 5) Mother or baby is known to have HIV, hepatitis B, herpes zoster or immuno-deficiency (6) Baby has already received BCG (7) Family refuses consent

Design outcomes

Primary

MeasureTime frame
The primary endpoint for the trial will be mortality up to 28 days of age with censoring at the time of loss to follow-up or any vaccination (other than BCG-Green Signal and OPV in the BCG group), and adjusted for age at the time of randomization, survival dependence between twins, and for birth weight, gestation, sex, season, and whether the baby was inborn or out bornTimepoint: 0 to 28 days

Secondary

MeasureTime frame
Time from randomization to death in the first 28 days of life. Both the primary and secondary endpoints will be analyzed separately for babies of mothers with and without a BCG scar.Timepoint: 0 to 28 days

Countries

India

Contacts

Public ContactChinnathambi Kamalarathnam

Institute of Child Health and Hospital for Children

drkamal.rathnam@gmail.com9790789376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026